Lamictal

Lamotrigine, the active ingredient in Lamictal, is an anticonvulsant presented as an oral tablet for oral use. It is prescribed for the management of epilepsy and for mood stabilization in bipolar disorder, acting on neuronal excitability in the central nervous system. Lamotrigine belongs to the class of voltage‑gated sodium channel blockers and is approved for use in adult and pediatric populations under medical supervision.

GNH USA supplies Lamictal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamotrigine is an anticonvulsant that modulates neuronal firing in seizure disorders and mood disorders. - Epilepsy: reduces the frequency and severity of partial and generalized seizures. - Bipolar disorder: helps maintain mood stability and prevents depressive episodes. - Seizure prophylaxis in patients with brain injury: lowers the risk of new‑onset seizures after traumatic events.

Lamotrigine may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Rash or mild skin irritation. - Headache. - Dizziness or vertigo. - Nausea or gastrointestinal discomfort. - Fatigue.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Severe hypersensitivity reactions (e.g., facial swelling, difficulty breathing). - Aseptic meningitis. - Blood dyscrasias such as agranulocytosis. - Hepatotoxicity. - Suicidal thoughts or behavior.

When prescribing lamotrigine, clinicians should consider several safety measures. - Initiate therapy at low dose: start with a minimal dose and titrate slowly to reduce rash risk. - Monitor skin reactions: discontinue immediately if a widespread rash develops. - Assess hepatic function: adjust dosing in patients with liver impairment. - Review concomitant medications: avoid drugs that significantly alter lamotrigine levels. - Store at ambient temperature: keep below 25°C, in the original packaging, protected from moisture.

Lamotrigine interacts with several medicines that can alter its plasma concentration.

Major Interactions (Avoid): - Valproate: markedly increases lamotrigine levels, raising risk of severe rash. - Carbamazepine: reduces lamotrigine concentrations, potentially decreasing efficacy. - Oral contraceptives: may lower lamotrigine levels, requiring dose adjustment.

Moderate Interactions (Monitor Closely): - Phenobarbital, phenytoin, primidone: induce metabolism, lowering lamotrigine exposure. - Serotonergic agents (e.g., SSRIs, SNRIs): may increase risk of serotonin syndrome. - Other antiepileptic drugs (e.g., topiramate, levetiracetam): require periodic therapeutic monitoring.